Pfizer to acquire Biohaven Pharma for $11.6 billion
Posted on11 May 2022
Comments0
Pfizer entered into a definitive agreement under which Pfizer will acquire Biohaven for 11.6 billion $. Biohen is the maker of Nurtec... Read More
Torrent Pharma to manufacture and sell Pfizer’s Paxlovid generic
Torrent Pharmaceuticals Limited (TPL) has announced that it has signed a non-exclusive, non-transferable, non-sub licensable, license agreement to use the patents and... Read More
Case Study: Pfizer’s Arena acquisition – A $6.7B deal
Pfizer will acquire Arena Pharmaceuticals for $6.7 billion to expand its pipeline of immuno-inflammatory disease drugs in development. Why Pfizer acquired Arena?... Read More
Insight on licensing deal of Pfizer and The Medicines Patent Pool for COVID-19 Oral Antiviral Treatment Candidate to Expand market Access in Low- and Middle-Income Countries
Posted on18 Nov 2021
Comments0
Pfizer and the Medicines Patent Pool (MPP), a United Nations-backed public health organization working to increase access to life-saving medicines for low-... Read More
EMA authorises Pfizer covid vaccine “Comirnaty” for 12-15 yrs
EMA has recommended granting an extension of indication for the COVID-19 vaccine Comirnaty to include use in children aged 12 to 15.... Read More
Insight on US FDA approval of Myfembree OD treatment for management of heavy menstrual bleeding associated with uterine fibroids
Myovant Sciences and Pfizer announced that the US Food and Drug Administration (FDA) has approved Myfembree (relugolix 40 mg, estradiol 1 mg,... Read More
Case Study: Pfizer acquires Amplyx Pharmaceuticals
Pfizer has bought privately held Amplyx Pharmaceuticals for an undisclosed sum, gaining experimental antifungal and antiviral treatments as the world’s attention turns... Read More
Myovant and Pfizer’s $4.2 Billion Deal for Orgovyx
Myovant Sciences is partnering with Pfizer to develop and commercialize Orgovyx for prostate cancer and women’s health. Orgovyx is the brand of... Read More
UK approves Pfizer-BioNTech’s COVID-19 vaccine. Rollout in week time
The UK today became the first country to approve the Covid-19 vaccine developed by Pfizer Inc and its German partner BioNTech SE.... Read More
Pfizer’s Hospital Business acquires Arixa Pharma
Posted on24 Oct 2020
Comments0
Arixa Pharmaceuticals, a company developing next-generation oral antibiotics for drug-resistant Gram-negative infections announced that Pfizer’s Hospital Business has agreed to acquire Arixa.... Read More